Cargando…

Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases

Detalles Bibliográficos
Autores principales: Garg, Neeraj K., Tandel, Nikunj, Bhadada, Sanjay Kumar, Tyagi, Rajeev K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455630/
https://www.ncbi.nlm.nih.gov/pubmed/36091766
http://dx.doi.org/10.3389/fphar.2022.1002649
_version_ 1784785621273804800
author Garg, Neeraj K.
Tandel, Nikunj
Bhadada, Sanjay Kumar
Tyagi, Rajeev K.
author_facet Garg, Neeraj K.
Tandel, Nikunj
Bhadada, Sanjay Kumar
Tyagi, Rajeev K.
author_sort Garg, Neeraj K.
collection PubMed
description
format Online
Article
Text
id pubmed-9455630
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94556302022-09-09 Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases Garg, Neeraj K. Tandel, Nikunj Bhadada, Sanjay Kumar Tyagi, Rajeev K. Front Pharmacol Pharmacology Frontiers Media S.A. 2022-08-25 /pmc/articles/PMC9455630/ /pubmed/36091766 http://dx.doi.org/10.3389/fphar.2022.1002649 Text en Copyright © 2022 Garg, Tandel, Bhadada and Tyagi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Garg, Neeraj K.
Tandel, Nikunj
Bhadada, Sanjay Kumar
Tyagi, Rajeev K.
Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases
title Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases
title_full Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases
title_fullStr Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases
title_full_unstemmed Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases
title_short Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases
title_sort corrigendum: nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455630/
https://www.ncbi.nlm.nih.gov/pubmed/36091766
http://dx.doi.org/10.3389/fphar.2022.1002649
work_keys_str_mv AT gargneerajk corrigendumnanostructuredlipidcarriermediatedtransdermaldeliveryofaceclofenachydrogelpresentaneffectivetherapeuticapproachforinflammatorydiseases
AT tandelnikunj corrigendumnanostructuredlipidcarriermediatedtransdermaldeliveryofaceclofenachydrogelpresentaneffectivetherapeuticapproachforinflammatorydiseases
AT bhadadasanjaykumar corrigendumnanostructuredlipidcarriermediatedtransdermaldeliveryofaceclofenachydrogelpresentaneffectivetherapeuticapproachforinflammatorydiseases
AT tyagirajeevk corrigendumnanostructuredlipidcarriermediatedtransdermaldeliveryofaceclofenachydrogelpresentaneffectivetherapeuticapproachforinflammatorydiseases